Literature DB >> 12657437

[Antiphospholipid antibodies in HELLP syndrome: clinical and biological study in 68 women].

V Queyrel1, A-S Ducloy-Bouthors, U Michon-Pasturel, E Hachulla, S Dubucquoi, C Caron, A-S Vallat, D Subtil, P Dufour, M Lambert, P-Y Hatron, B Devulder, F Puech.   

Abstract

PURPOSE: Pregnancy complicated by the HELLP syndrome and antiphospholipid syndrome have rarely been reported. We report a study on anticardiolipin antibodies in HELLP syndrome.
METHODS: Between March 1996 and September 1999, anticardiolipin antibodies were checked in all women with HELLP syndrome hospitalised in a maternity of the North of France. The women with positive anticardiolipin antibodies were seen month later in a internal medicine department.
RESULTS: In the period 68 women with HELLP syndrome were checked for anticardiolipin antibodies. Apl were present in 9 patients (Incidence 42.8/1000 HELLP Year). They persisted after the accident only in 3 patients. Antiphospholipid syndrome was diagnosed in 2 patients, prevalence between the HELLP syndrome for the 42 month period was 0.03.
CONCLUSIONS: HELLP syndrome may be a manifestation linked to the antiphospholipid syndrome and may revealed it.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657437     DOI: 10.1016/s0248-8663(02)00013-9

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome.

Authors:  Martial Koenig; Michel Roy; Sylviane Baccot; Muriel Cuilleron; Jean-Pierre de Filippis; Pascal Cathébras
Journal:  Clin Rheumatol       Date:  2004-12-08       Impact factor: 2.980

Review 2.  The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.

Authors:  D Le Thi Thuong; N Tieulié; N Costedoat; M-R Andreu; B Wechsler; D Vauthier-Brouzes; O Aumaître; J-C Piette
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

Review 3.  Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome.

Authors:  Panagiotis Tsirigotis; George Mantzios; Vassiliki Pappa; Konstantinos Girkas; George Salamalekis; Angellos Koutras; Vassiliki Giannopoulou; Konstantina Spirou; Alexia Balanika; Sotirios Papageorgiou; Anthi Travlou; John Dervenoulas
Journal:  Rheumatol Int       Date:  2007-06-19       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.